ProShare Advisors
VTAE

ProShare Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

ProShare Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,788
Closed -$435K – 1780
2016
Q3 		$435K Sell
20,788
-3,898
-16% -$44.9K 0.01% 1001
2016
Q2 		$266K Buy
24,686
+6,991
+40% +$59.8K ﹤0.01% 1265
2016
Q1 		$117K Sell
17,695
-1,821
-9% -$16.6K ﹤0.01% 1502
2015
Q4 		$353K Buy
+19,516
New +$269K ﹤0.01% 1213

ProShare Advisors's VTAE Position: Q4 2016 in Review

ProShare Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 20,788 shares — an estimated $435K sold.

ProShare Advisors first reported a position in VTAE in Q4 2015 and held it in 4 quarters. The position peaked at $435K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • ProShare Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • ProShare Advisors sold 20,788 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $435K.
  • ProShare Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2015 and held it in 4 quarters.
  • ProShare Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $435K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.